Selective synthesis of 2,5-disubstituted furan-3-carboxylates and the isomeric 2,4-disubstituted furan-3-carboxylates

Panpan Chena, Yinggao Menga, Qinghua Yangb, Jie Wu*a, Yuanyuan Xiaoa, Dhilli Rao Gorjac, Chuanjun Song*a and Junbiao Chang*a
aCollege of Chemistry and Molecular Engineering, Zhengzhou University, 100 Science Avenue, Zhengzhou 450001, P. R. China. E-mail: changjunbiao@zzu.edu.cn; chjsong@zzu.edu.cn; wujie@zzu.edu.cn
bSchool of Pharmaceutical Sciences, Zhengzhou University, 100 Science Avenue, Zhengzhou 450001, P. R. China
cChina-US (Henan) Hormel Cancer Institute, 127 Dongming Road, Zhengzhou 450003, P. R. China

Received 20th July 2015 , Accepted 15th September 2015

First published on 16th September 2015


Abstract

An unprecedented Ag2CO3 and DBU mediated cyclization of 3-substituted 2-(2-bromoallyl)-3-oxo-1-carboxylates leading to the formation of 2,5-disubstituted furan-3-carboxylates has been reported. In the absence of a silver salt, the isomeric 2,4-disubstituted furan-3-carboxylates are obtained.


Introduction

Furans are a fundamental class of five-membered heterocycles. Especially, functionalized furans play an important role as structural elements of many natural products (e.g. pochonin G I,1 sarcofuranocembrenolide B II,2 and the sesquiterpenoid III3 isolated from the mycelia of the edible mushroom Pleurotus cornucopiae fermented on rice, Fig. 1) which have shown diverse biological properties, such as hair-growth stimulation,1 antiallergic,2 antiapoptotic,2 and anticancer activities.3 Moreover, they are important building blocks in organic synthesis.4 Therefore, the synthesis of furans has attracted a great deal of attention from synthetic organic chemists. Generally, there are two strategies to construct the furan ring: (i) Paal–Knorr synthesis,5 i.e. cyclization of 1,4-dicarbonyl compounds; (ii) cyclization of propargyl/allyl dicarbonyl compounds,6 allenyl ketones,7 enynols,8 alkynyl epoxides9 or propargyl ethers.10 Transition metals, PhI(O2CCF3)2, PhSeSePh, NBS and even iodine could be used as catalysts for these transformations to obtain highly substituted furans.
image file: c5ra14273c-f1.tif
Fig. 1 Representative furan natural products.

Over the last decades, silver-mediated cyclization for the construction of heterocyclic compounds has received considerable attention.11 Recently, Lei and co-worker have developed useful silver-mediated oxidative cross-coupling/cyclization strategies between 2-aminopyridines,12 1,3-dicarbonyl compounds,13 β-enamino esters14 and terminal alkynes to create polysubstituted imidazole[1,2-a]pyridines, furans, and pyrroles, respectively. Silver-mediated intramolecular addition of heteroatoms to acetylene,15 alkene,16 and allenic intermediates17 has also been widely applied in the assembly of bioactive heterocycles. Given that 3-substituted 2-(2-bromoallyl)-3-oxo-1-carboxylates 1 could be easily accessed through nucleophilic substitution of 2,3-dibromo-1-propene with 3-oxo-1-propanoates,6j,18 we wonder a silver-mediated cyclization would lead to the formation of furan-3-carboxylates 2 (Scheme 1). To the best of our knowledge, this demonstration represents the first silver-mediated cyclization of 3-substituted 2-(2-bromoallyl)-3-oxo-1-carboxylates to poly-substituted furans.


image file: c5ra14273c-s1.tif
Scheme 1 Proposed silver-mediated cyclization to form 2,5-disubstituted furan-3-carboxylates.

Results and discussion

Initial study was carried out with methyl 2-benzoyl-4-bromopent-4-enoate 1a, which was treated with 2 equivalent of DBU and a catalytic amount of Ag2CO3 (0.05 eq.) at 60 °C (entry 1, Table 1). When the reaction was complete (6 h), two main spots appeared on the TLC plate. After being separated by column chromatography, the two products were found to be the desired furan 2a and the isomerized product 3a, respectively. Inspired by the results, we then optimized the reaction conditions in order to obtain either regioisomer selectively.
Table 1 Optimization of the reaction conditions for the selective formation of 2a or 3a, respectivelya

image file: c5ra14273c-u1.tif

Entry Base Silver salt Temperature (°C) Reaction time (h) Ratio of 2a[thin space (1/6-em)]:[thin space (1/6-em)]3a Yield (%)
a Anhydrous DMF was found to be the most appropriate solvent through screening.b Numbers in parenthesis indicated the equivalents of reagents used.c Ratio determined on the basis of 1H NMR integration of the crude reaction mixture.d No reaction.e Isolated yields.
1 DBU (2)b Ag2CO3 (0.05)b 60 6 1[thin space (1/6-em)]:[thin space (1/6-em)]3c  
2 DBU (2)b AgNO3/silica gel (0.05)b 60 6 1[thin space (1/6-em)]:[thin space (1/6-em)]8c  
3 DBU (2)b Ag2CO3 (0.25)b 60 5.5 1[thin space (1/6-em)]:[thin space (1/6-em)]0.15c  
4 DBU (2)b Ag2CO3 (0.35)b 60 4 1[thin space (1/6-em)]:[thin space (1/6-em)]0.03c  
5 DBU (2)b Ag2CO3 (0.4)b 60 3.5 1[thin space (1/6-em)]:[thin space (1/6-em)]0.02c  
6 DBU (2)b Ag2CO3 (0.5)b 60 1 1[thin space (1/6-em)]:[thin space (1/6-em)]0 83e
7 Cs2CO3 (2)b Ag2CO3 (0.5)b 60 1 1[thin space (1/6-em)]:[thin space (1/6-em)]0.14c  
8 Ag2CO3 (0.5)b 60 20 d  
9 DBU (2)b 60 12 0[thin space (1/6-em)]:[thin space (1/6-em)]1 45e
10 K3PO4 (2)b 60 25 0[thin space (1/6-em)]:[thin space (1/6-em)]1 60e
11 NaHCO3 (2)b 60 22 0[thin space (1/6-em)]:[thin space (1/6-em)]1 40e
12 K2CO3 (2)b 60 4 0[thin space (1/6-em)]:[thin space (1/6-em)]1 74e
13 Cs2CO3 (2)b 60 3 0[thin space (1/6-em)]:[thin space (1/6-em)]1 78e
14 Cs2CO3 (2)b 40 9 0[thin space (1/6-em)]:[thin space (1/6-em)]1 46e
15 Cs2CO3 (2)b 50 8 0[thin space (1/6-em)]:[thin space (1/6-em)]1 70e
16 Cs2CO3 (2)b 70 1 0[thin space (1/6-em)]:[thin space (1/6-em)]1 85e
17 Cs2CO3 (2)b 80 0.7 0[thin space (1/6-em)]:[thin space (1/6-em)]1 92e
18 Cs2CO3 (2)b 90 0.6 0[thin space (1/6-em)]:[thin space (1/6-em)]1 89e
19 Cs2CO3 (1)b 80 0.7 0[thin space (1/6-em)]:[thin space (1/6-em)]1 92e
20 Cs2CO3 (0.75)b 80 0.7 0[thin space (1/6-em)]:[thin space (1/6-em)]1 92e
21 Cs2CO3 (0.5)b 80 0.7 0[thin space (1/6-em)]:[thin space (1/6-em)]1 70e


In the presence of 2 equivalent of DBU, the ratio of 2a[thin space (1/6-em)]:[thin space (1/6-em)]3a improved with increased loading of Ag2CO3 (entries 1 and 3–6, Table 1). When 0.5 equivalent of Ag2CO3 was used, 2a was isolated as the sole product in 83% yield (entry 6). The ratio of 2a[thin space (1/6-em)]:[thin space (1/6-em)]3a decreased either changing the base from DBU to Cs2CO3 (entry 7 vs. 6), or changing the silver salt from Ag2CO3 to AgNO3/silica gel (entry 2 vs. 1). In the absence of a base, no reaction occurred at all (entry 8). When silver salt was removed from the reaction system, isomer 3a was the only product obtained although the reaction proceeded slowly and only moderate yield was obtained (entry 9). Inspired by the findings and in order to obtain 3a selectively, we then explored other bases. Similar to DBU, when conducted in the presence of K3PO4 or NaHCO3, the reaction was sluggish and 3a was isolated in a moderate yield (entries 10 and 11). To our delight, when K2CO3 was applied, the reaction was complete in much shorter time and 3a was isolated in good yield (entry 12). Even better result was obtained when Cs2CO3 was used (entry 13). With Cs2CO3 as our optimized base, we next investigated the effect of the reaction temperature. The reaction proceeded slowly at temperatures below 60 °C while the yield of 3a was moderate (entries 14 and 15). By contrast, at temperatures above 60 °C, the reaction proceeded much faster and the product yield was higher (entries 16–18). When the reaction was conducted at 80 °C, 3a was isolated in the highest yield (92%) (entry 17). Slightly less satisfactory result was obtained when the reaction temperature was raised to 90 °C (entry 18). Finally, we inspected the effect of the quantities of Cs2CO3 to the reaction (entries 17 and 19–21) and found that the reaction could work equally well when as low as 0.75 equivalent of the base was applied (entry 20). Further reduction of the amount of Cs2CO3 resulted in reduced yield of the product (entry 21).

Having the optimized reaction conditions in hand, we then tested the generality and scope of the present 2,5-disubstituted furan-3-carboxylates and 2,4-disubstituted furan-3-carboxylates, and the results were collected in Table 2. In the presence of 0.5 equivalent of Ag2CO3 and 2 equivalent of DBU, the reactions of 3-aryl substituted substrates 1 bearing either an electron-donating group (entries 2 and 3) or electron-withdrawing group (entries 4–6) at the phenyl ring proceeded smoothly to give 2,5-disubstituted furan-3-carboxylates 2b–f in good yields. However, reaction of substrate 1g having a 2,4-dimethoxyphenyl ring gave 2g in poor yield (entry 7). Under the reaction conditions, both substrates bearing naphthalyl and protected pyrrolyl group (1h and 1i) could cyclize to afford good yields of the expected products 2h and 2i, respectively (entries 8 and 9). The structure of 2i was unambiguously confirmed by X-ray single crystal diffraction (Fig. 2).19 Aliphatic β-keto esters 1k and 1l (entries 11 and 12), as well as substrates with a substituted 2-bromoallyl moiety 1m–o (entries 13–15) could also be converted into the corresponding furan-3-carboxylates 2k–o in good to excellent isolated yield. To our delight, trifuran 2j was obtained in good yield starting from 1j (entry 10). On the other hand, in the presence of 0.75 equivalent of Cs2CO3, most substrates reacted smoothly to give 2,4-disubstituted furan-3-carboxylates in good to excellent isolated yield (entries 1–13 and 15). In general, substrates bearing electron-donating groups at the phenyl ring (entries 2, 3 and 7) gave higher yields than those bearing electron-withdrawing groups (entries 4 and 5). Quite unexpectedly, reaction of substrate 1n was sluggish. After 25 h, the desired product 2n was isolated in 11% yield together with substantial amount (75%) of the unreacted starting material recovered.

Table 2 Substrate scope for the selective formation of 2,5-disubstituted furan-3-carboxylates 2 or 2,4-disubstituted furan-3-carboxylates 3, respectively

image file: c5ra14273c-u2.tif

Entry Substrate 2,5-Disubstituted furan-3-carboxylates 2,4-Disubstituted furan-3-carboxylates
a 75% of the unreacted 1n was recovered.
1 image file: c5ra14273c-u3.tif image file: c5ra14273c-u4.tif image file: c5ra14273c-u5.tif
2 image file: c5ra14273c-u6.tif image file: c5ra14273c-u7.tif image file: c5ra14273c-u8.tif
3 image file: c5ra14273c-u9.tif image file: c5ra14273c-u10.tif image file: c5ra14273c-u11.tif
4 image file: c5ra14273c-u12.tif image file: c5ra14273c-u13.tif image file: c5ra14273c-u14.tif
5 image file: c5ra14273c-u15.tif image file: c5ra14273c-u16.tif image file: c5ra14273c-u17.tif
6 image file: c5ra14273c-u18.tif image file: c5ra14273c-u19.tif image file: c5ra14273c-u20.tif
7 image file: c5ra14273c-u21.tif image file: c5ra14273c-u22.tif image file: c5ra14273c-u23.tif
8 image file: c5ra14273c-u24.tif image file: c5ra14273c-u25.tif image file: c5ra14273c-u26.tif
9 image file: c5ra14273c-u27.tif image file: c5ra14273c-u28.tif image file: c5ra14273c-u29.tif
10 image file: c5ra14273c-u30.tif image file: c5ra14273c-u31.tif image file: c5ra14273c-u32.tif
11 image file: c5ra14273c-u33.tif image file: c5ra14273c-u34.tif image file: c5ra14273c-u35.tif
12 image file: c5ra14273c-u36.tif image file: c5ra14273c-u37.tif image file: c5ra14273c-u38.tif
13 image file: c5ra14273c-u39.tif image file: c5ra14273c-u40.tif image file: c5ra14273c-u41.tif
14 image file: c5ra14273c-u42.tif image file: c5ra14273c-u43.tif image file: c5ra14273c-u44.tif
15 image file: c5ra14273c-u45.tif image file: c5ra14273c-u46.tif image file: c5ra14273c-u47.tif



image file: c5ra14273c-f2.tif
Fig. 2 X-ray single crystal structure of 2i.

Based on the above results and literature reports, plausible mechanisms for the regioselective formation of 2,5-disubstituted furan-3-carboxylates 2 and 2,4-disubstituted furan-3-carboxylates 3 were proposed in Scheme 2. Base promoted elimination of 1 generated the allenic intermediate I. Intramolecular attack of the allene function with the enolate carbon gave methylenecyclopropane III.20 Activation of the double bond in III with silver7b,21 (path a) followed by concomitant cyclopropane ring opening and cyclization would generate V.22 β-Elimination of V gave VI, which aromatized to produce furan 2 by tautomerization. On the other hand, in the absence of silver salt, cyclopropane ring opening and subsequent intramolecular nucleophilic attack at the less sterically hindered carbon atom in the cyclopropane ring20,23 (path b) would generate VII, which tautomerized to produce 2,4-disubstituted furan-3-carboxylates 3.


image file: c5ra14273c-s2.tif
Scheme 2 Proposed mechanism for the regioselective formation of 2,5-disubstituted furan-3-carboxylates 2 and 2,4-disubstituted furan-3-carboxylates 3.

Conclusion

In summary, we have developed a valuable approach towards the synthesis of 2,5-disubstituted furan-3-carboxylates and the isomeric 2,4-disubstituted furan-3-carboxylates. The former was accessed by treatment of 3-substituted 2-(2-bromoallyl)-3-oxo-1-carboxylates with Ag2CO3/DBU, while the latter could be easily obtained by treatment of the same substrates with Cs2CO3.

Experimental section

General information

Melting points were determined on a XT4A hot-stage apparatus and are uncorrected. IR spectra were obtained using an IFS25 FT-IR spectrometer. 1H and 13C NMR spectra were obtained on a Agilent AV400 instrument. High-resolution mass spectra were recorded on a Micromass Q-TOF mass spectrometer. Flash column chromatography was performed over silica gel 200–300 mesh.

General procedure for the synthesis of 2,5-disubstituted furan-3-carboxylates (2a–o)

DBU (2.0 mmol) and silver carbonate (0.5 mmol) were added to a solution of 3-substituted 2-(2-bromoallyl)-3-oxo-1-carboxylates (1a–o) (1.0 mmol) in anhydrous DMF (15 mL). The resulting mixture was stirred at 60 °C until the substrate was consumed (monitored by TLC). After being cooled to ambient temperature, the mixture was treated with 1 M HCl (5 mL) and filtered. The filtrate was extracted with ethyl acetate (10 mL × 3). The combined organic extracts were washed with brine (10 mL), then dried over anhydrous sodium sulphate, filtered and concentrated in vacuo. The residue was purified by column chromatography on silica gel to afford 2,3,5-trisubstituted furans 2a–o.
Methyl 5-methyl-2-phenylfuran-3-carboxylate (2a)6a. The crude product was purified by column chromatography on silica gel (1% ethyl acetate in petroleum ether) to give 2a as a colorless oil; yield 83%; 1H NMR (400 MHz, CDCl3): δ 7.97–7.95 (m, 2H), 7.44–7.35 (m, 3H), 6.43 (s, 1H), 3.81 (s, 3H), 2.35 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 164.4, 156.2, 151.3, 130.1, 129.1, 128.1, 114.2, 108.8, 51.6, 51.4, 13.5; IR (neat): νmax/cm−1 1721, 1559, 1492, 1435, 1378, 1274, 1212, 1097, 1016; HRMS (ESI): m/z calcd for C13H13O3: 217.0859 [M + H]+; found 217.0859.
Methyl 5-methyl-2-(4′-methylphenyl)furan-3-carboxylate (2b)6a. The crude product was purified by column chromatography on silica gel (0.5% ethyl acetate in petroleum ether) to give 2b as an orange oil; yield 70%; 1H NMR (400 MHz, CDCl3): δ 7.86 (d, J = 8.0 Hz, 2H), 7.23 (d, J = 8.0 Hz, 2H), 6.41 (s, 1H), 3.80 (s, 3H), 2.39 (s, 3H), 2.34 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 164.4, 156.6, 150.9, 139.2, 128.9, 128.1, 127.3, 113.6, 108.7, 51.6, 21.5, 13.5; IR (neat): νmax/cm−1 1719, 1587, 1480, 1381, 1223, 1086; HRMS (ESI): m/z calcd for C14H15O3: 231.1016 [M + H]+; found 231.1016.
Methyl 2-(4′-methoxyphenyl)-5-methylfuran-3-carboxylate (2c). The crude product was purified by column chromatography on silica gel (5% ethyl acetate in petroleum ether) to give 2c as an orange oil; yield 75%; 1H NMR (400 MHz, CDCl3): δ 7.98–7.94 (m, 2H), 6.99–6.95 (m, 2H), 6.41 (q, J = 1.0 Hz, 1H), 3.87 (s, 3H), 3.83 (s, 3H), 2.35 (d, J = 1.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 164.4, 160.2, 156.4, 150.5, 129.6, 122.7, 113.5, 112.8, 108.5, 55.3, 51.4, 13.3; IR (neat): νmax/cm−1 1717, 1609, 1580, 1504, 1440, 1378, 1303, 1210; HRMS (ESI): m/z calcd for C14H15O4: 247.0965 [M + H]+; found 247.0962.
Ethyl 5-methyl-2-(4′-nitrophenyl)furan-3-carboxylate (2d). The crude product was purified by column chromatography on silica gel (3% ethyl acetate in petroleum ether) to give 2d as a yellow solid; yield 74%; mp 72 °C; 1H NMR (400 MHz, CDCl3): δ 8.25–8.20 (m, 4H), 6.50 (q, J = 1.0 Hz, 1H), 4.31 (q, J = 7.2 Hz, 2H), 2.38 (d, J = 1.0 Hz, 1H), 1.35 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 163.4, 153.0, 152.8, 147.3, 135.8, 128.4, 123.5, 117.7, 110.0, 61.0, 14.3, 13.5; IR (KBr): νmax/cm−1 1724, 1598, 1569, 1516, 1354, 1313, 1300, 1281, 1260, 1215, 1095, 1028; HRMS (ESI): m/z calcd for C14H14NO5: 276.0866 [M + H]+; found 276.0865.
Methyl 5-methyl-2-(3′-trifluoromethylphenyl)furan-3-carboxylate (2e). The crude product was purified by column chromatography on silica gel (0.5% ethyl acetate in petroleum ether) to give 2e as an orange oil; yield 69%; 1H NMR (400 MHz, CDCl3): δ 8.27 (s, 1H), 8.22 (d, J = 7.8 Hz, 1H), 7.61 (d, J = 7.8 Hz, 1H), 7.53 (t, J = 7.8 Hz, 1H), 6.46 (s, 1H), 3.83 (s, 3H), 2.37 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 163.9, 154.1, 151.9, 131.1 (q, JF–C = 1.2 Hz), 130.6, 130.5 (q, JF–C = 32.3 Hz), 128.5, 125.3 (q, JF–C = 3.7 Hz), 124.8 (q, JF–C = 4.0 Hz), 124.0 (q, JF–C = 270.8 Hz), 115.3, 109.1, 51.7, 13.4; IR (neat): νmax/cm−1 1722, 1558, 1439, 1380, 1330, 1268, 1215, 1168, 1127, 1102, 1030; HRMS (ESI): m/z calcd for C14H12F3O3: 285.0733 [M + H]+; found 285.0723.
Methyl 2-(2′-bromophenyl)-5-methylfuran-3-carboxylate (2f). The crude product was purified by column chromatography on silica gel (2% ethyl acetate in petroleum ether) to give 2f as a colorless oil; yield 85%; 1H NMR (400 MHz, CDCl3): δ 7.57 (m, 1H), 7.37 (m, 1H), 7.29 (m, 1H), 7.20 (m, 1H), 6.36 (q, J = 1.0 Hz, 1H), 3.62 (s, 3H), 2.28 (d, J = 1.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 163.8, 155.0, 152.3, 132.9, 132.3, 132.1, 130.8, 126.9, 124.0, 116.7, 107.2, 51.6, 13.6; IR (neat): νmax/cm−1 1723, 1570, 1467, 1438, 1383, 1275, 1209, 1102, 1058; HRMS (ESI): m/z calcd for C13H1279BrO3: 294.9964 [M + H]+; found 294.9963.
Methyl 2-(2′,4′-dimethoxyphenyl)-5-methylfuran-3-carboxylate (2g). The crude product was purified by column chromatography on silica gel (7% ethyl acetate in petroleum ether) to give 2g as a colorless oil; yield 38%; 1H NMR (400 MHz, CDCl3): δ 7.36 (d, J = 8.4 Hz, 1H), 6.56–6.49 (m, 2H), 6.37 (q, J = 1.0 Hz, 1H), 3.83 (s, 3H), 3.76 (s, 3H), 3.70 (s, 3H), 2.32 (d, J = 1.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 164.4, 161.9, 158.5, 153.5, 151.1, 138.8, 131.9, 115.5, 107.2, 104.3, 98.7, 55.6, 55.4, 51.2, 13.4; IR (neat): νmax/cm−1 1719, 1623, 1582, 1504, 1438, 1280, 1209, 1090, 1032; HRMS (ESI): m/z calcd for C15H17O5: 277.1071 [M + H]+; found 277.1073.
Methyl 2-(6′-methoxynaphthalen-2′-yl)-5-methylfuran-3-carboxylate (2h). The crude product was purified by column chromatography on silica gel (10% ethyl acetate in petroleum ether) to give 2h as a yellow solid; yield 65%; mp 77 °C; 1H NMR (400 MHz, CDCl3): δ 8.46 (m, 1H), 8.03 (m, 2H), 7.81 (m, 1H), 7.76 (m, 1H), 7.17–7.13 (m, 2H), 6.45 (q, J = 1.0 Hz, 1H), 3.94 (s, 3H), 3.83 (s, 3H), 2.38 (d, J = 1.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 164.4, 158.4, 156.4, 151.0, 134.7, 130.3, 128.4, 127.6, 126.4, 125.9, 119.1, 113.8, 108.8, 105.6, 55.3, 51.5, 29.7, 13.4; IR (KBr): νmax/cm−1 1714, 1626, 1602, 1548, 1496, 1392, 1278, 1259, 1202, 1164, 1092, 1031; HRMS (ESI): m/z calcd for C18H16NaO4: 319.0941 [M + Na]+; found 319.0943.
Methyl 5-methyl-2-(N-tosyl-1H-pyrrol-3′-yl)furan-3-carboxylate (2i). The crude product was purified by column chromatography on silica gel (10% ethyl acetate in petroleum ether) to give 2i as a colorless solid; yield 68%; mp 111 °C; 1H NMR (400 MHz, CDCl3): δ 8.14 (m, 1H), 7.84–7.82 (m, 2H), 7.31 (m, 2H), 7.18 (m, 1H), 6.94 (m, 1H), 6.33 (q, J = 1.2 Hz, 1H), 3.85 (s, 3H), 2.41 (s, 3H), 2.31 (d, J = 1.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 164.2, 151.6, 150.4, 145.3, 135.9, 130.2, 127.2, 120.8, 119.1, 113.0, 112.8, 108.1, 51.5, 21.8, 13.4; IR (KBr): νmax/cm−1 1713, 1649, 1620, 1594, 1439, 1366, 1293, 1266, 1258, 1189, 1173, 1086; HRMS (ESI): m/z calcd for C18H17NNaO5S: 382.0720 [M + Na]+; found 382.0729.
Diethyl 5,5′′-dimethyl-[2,2′:5′,2′′-terfuran]-3,3′′-dicarboxylate (2j). The crude product was purified by column chromatography on silica gel (2% ethyl acetate in petroleum ether) to give 2j as a yellow solid; yield 64%; mp 80 °C; 1H NMR (400 MHz, CDCl3): δ 7.60 (s, 2H), 6.43 (q, J = 1.2 Hz, 2H), 4.33 (q, J = 7.1 Hz, 4H), 2.40 (d, J = 1.2 Hz, 6H), 1.37 (t, J = 7.1 Hz, 6H); 13C NMR (100 MHz, CDCl3): δ 163.2, 151.8, 147.0, 144.8, 144.7, 114.6, 108.7, 60.6, 14.5, 13.7; IR (KBr): νmax/cm−1 1713, 1607, 1538, 1378, 1261, 1215, 1100, 1052, 1024; HRMS (ESI): m/z calcd for C20H20NaO7: 395.1101 [M + Na]+; found 395.1100.
Ethyl 2,5-dimethylfuran-3-carboxylate (2k). The crude product was purified by column chromatography on silica gel (petroleum ether) to give 2k as a yellow oil; yield 88%; 1H NMR (400 MHz, CDCl3): δ 6.20 (q, J = 0.8 Hz, 1H), 4.25 (q, J = 7.1 Hz, 2H), 2.51 (s, 3H), 2.23 (d, J = 0.8 Hz, 3H), 1.32 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 164.5, 157.7, 150.0, 114.1, 106.3, 60.0, 14.5, 13.8, 13.3; IR (neat): νmax/cm−1 1716, 1624, 1590, 1406, 1283, 1231, 1206, 1083; HRMS (ESI): m/z calcd for C9H13O3: 169.0859 [M + H]+; found 169.0858.
Ethyl 2-isopropyl-5-methylfuran-3-carboxylate (2l). The crude product was purified by column chromatography on silica gel (petroleum ether) to give 2k as a colorless oil; yield 55%; 1H NMR (400 MHz, CDCl3): δ 6.19 (q, J = 1.0 Hz, 1H), 4.25 (q, J = 7.1 Hz, 2H), 3.71 (heptet, J = 7.0 Hz, 1H), 2.24 (d, J = 1.0 Hz, 3H), 1.32 (t, J = 7.1 Hz, 3H), 1.24 (d, J = 7.0 Hz, 6H); 13C NMR (100 MHz, CDCl3): δ 165.9, 164.4, 149.8, 112.1, 106.2, 60.0, 27.2, 21.0, 14.5, 13.4; IR (neat): νmax/cm−1 1724, 1469, 1250, 1214, 1069, 1025; HRMS (ESI): m/z calcd for C11H17O3: 197.1172 [M + H]+; found 197.1173.
Methyl 5-ethyl-2-(4′-methylphenyl)furan-3-carboxylate (2m). The crude product was purified by column chromatography on silica gel (petroleum ether) to give 2m as a yellow oil; yield 80%; 1H NMR (400 MHz, CDCl3): δ 7.85 (d, J = 8.3 Hz, 2H), 7.23 (d, J = 8.3 Hz, 2H), 6.41 (t, J = 0.9 Hz, 1H), 3.81 (s, 3H), 2.69 (qd, J = 7.6, 0.9 Hz, 2H), 2.39 (s, 3H), 1.28 (t, J = 7.6 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 164.5, 156.5, 156.4, 139.2, 128.9, 128.2, 127.4, 113.5, 107.2, 51.6, 21.6, 21.3, 12.0; IR (neat): νmax/cm−1 1721, 1504, 1290, 1233, 1099; HRMS (ESI): m/z calcd for C15H17O3: 245.1172 [M + H]+; found 245.1172.
Methyl 2-(4′-methylphenyl)-4,5,6,7-tetrahydrobenzofuran-3-carboxylate (2n). The crude product was purified by column chromatography on silica gel (petroleum ether) to give 2n as a colorless oil; yield 52%; 1H NMR (400 MHz, CDCl3): δ 7.72 (d, J = 8.2 Hz, 2H), 7.21 (d, J = 8.2 Hz, 2H), 3.79 (s, 3H), 2.66–2.61 (m, 4H), 2.38 (s, 3H), 1.88–1.73 (m, 4H); 13C NMR (100 MHz, CDCl3): δ 165.2, 156.3, 150.7, 138.9, 128.8, 128.3, 127.9, 119.1, 112.8, 51.3, 23.2, 23.0, 22.8, 22.7, 21.6; IR (neat): νmax/cm−1 1720, 1557, 1501, 1438, 1283, 1217, 1095, 1037; HRMS (ESI): m/z calcd for C17H19O3: 271.1329 [M + H]+; found 271.1328.
Ethyl 5-benzyl-2-isopropylfuran-3-carboxylate (2o). The crude product was purified by column chromatography on silica gel (0.3% ethyl acetate in petroleum ether) to give 2o as a colorless oil; yield 89%; 1H NMR (400 MHz, CDCl3): δ 7.33–7.22 (m, 5H), 6.18 (s, 1H), 4.24 (q, J = 7.2 Hz, 2H), 3.91 (s, 1H), 3.72 (heptet, J = 7.0 Hz, 1H), 1.30 (t, J = 7.2 Hz, 3H), 1.25 (d, J = 7.0 Hz, 6H); 13C NMR (100 MHz, CDCl3): δ 166.4, 164.2, 152.3, 137.7, 128.8, 128.6, 126.7, 112.2, 107.0, 60.0, 34.3, 27.3, 20.9, 14.5; IR (neat): νmax/cm−1 1715, 1576, 1496, 1468, 1455, 1380, 1208, 1059; HRMS (ESI): m/z calcd for C17H21O3: 273.1485 [M + H]+; found 273.1484.

General procedure for the synthesis of 2,4-disubstituted furan-3-carboxylates (3a–o)

Cesium carbonate (0.75 mmol, 244 mg) was added to a solution of 3-substituted 2-(2-bromoallyl)-3-oxo-1-carboxylates (1a–o) (1.0 mmol) in anhydrous DMF (15 mL). The resulting mixture was stirred at 80 °C until the substrate was consumed (monitored by TLC). After being cooled to ambient temperature, the mixture was treated with 1 M HCl (5 mL) and filtered. The filtrate was extracted with ethyl acetate (10 mL × 3). The combined organic extracts were washed with brine (10 mL), then dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The residue was purified by column chromatography on silica gel to afford 2,3,4-trisubstituted furans 3a–o.
Methyl 4-methyl-2-phenylfuran-3-carboxylate (3a)24. The crude product was purified by column chromatography on silica gel (0.5% ethyl acetate in petroleum ether) to give 3a as a colorless oil; yield 92%; 1H NMR (400 MHz, CDCl3): δ 7.78–7.76 (m, 2H), 7.43–7.37 (m, 3H), 7.24 (s, 1H), 3.80 (s, 3H), 2.19 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 165.1, 158.1, 139.3, 130.5, 129.2, 128.5, 128.1, 122.6, 114.1, 51.4, 10.3; IR (neat): νmax/cm−1 1717, 1490, 1436, 1290, 1066; HRMS (ESI): m/z calcd for C13H13O3: 217.0859 [M + H]+; found 217.0859.
Methyl 4-methyl-2-(4′-methylphenyl)furan-3-carboxylate (3b)24. The crude product was purified by column chromatography on silica gel (0.5% ethyl acetate in petroleum ether) to give 3b as an orange oil; yield 90%; 1H NMR (400 MHz, CDCl3): δ 7.68–7.66 (m, 2H), 7.24–7.22 (m, 3H), 3.81 (s, 3H), 2.39 (s, 3H), 2.20 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 165.1, 158.4, 139.2, 138.9, 128.8, 128.3, 127.6, 122.5, 113.5, 51.3, 21.5, 10.3; IR (neat): νmax/cm−1 1722, 1590, 1480, 1377, 1223, 1090; HRMS (ESI): m/z calcd for C14H15O3: 231.1016 [M + H]+; found 231.1018.
Methyl 2-(4′-methoxyphenyl)-4-methylfuran-3-carboxylate (3c). The crude product was purified by column chromatography on silica gel (1% ethyl acetate in petroleum ether) to give 3c as a yellow solid; yield 85%; mp 70 °C; 1H NMR (400 MHz, CDCl3): δ 7.76–7.73 (m, 2H), 6.41 (q, J = 1.0 Hz, 1H), 6.96–6.92 (m, 2H), 3.84 (s, 3H), 3.80 (s, 3H), 2.18 (d, J = 1.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 165.1, 160.3, 158.5, 138.7, 130.0, 123.1, 122.5, 113.6, 113.0, 55.4, 51.3, 10.4; IR (KBr): νmax/cm−1 1717, 1608, 1501, 1438, 1254, 1177, 1074, 1028; HRMS (ESI): m/z calcd for C14H14NaO4: 269.0784 [M + Na]+; found 269.0784.
Ethyl 4-methyl-2-(4′-nitrophenyl)furan-3-carboxylate (3d). The crude product was purified by column chromatography on silica gel (3% ethyl acetate in petroleum ether) to give 3d as a yellow solid; yield 58%; mp 83 °C; 1H NMR (400 MHz, CD3OD): δ 8.28 (m, 2H), 8.04 (m, 2H), 7.53 (s, 1H), 4.33 (q, J = 6.8 Hz, 2H), 2.22 (s, 3H), 1.33 (t, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CD3OD): δ 165.3, 155.9, 149.0, 142.4, 137.4, 130.0, 124.5, 124.3, 117.9, 61.9, 14.4, 10.1; IR (neat): νmax/cm−1 1712, 1616, 1591, 1545, 1520, 1488, 1474, 1382, 1348, 1297, 1280, 1100, 1072, 1024; HRMS (ESI): m/z calcd for C14H13NNaO5: 298.0686 [M + Na]+; found 298.0688.
Methyl 4-methyl-2-(3′-trifluoromethylphenyl)furan-3-carboxylate (3e). The crude product was purified by column chromatography on silica gel (1% ethyl acetate in petroleum ether) to give 3e as an orange oil; yield 65%; 1H NMR (400 MHz, CDCl3): δ 8.08 (s, 1H), 8.00 (d, J = 7.9 Hz, 1H), 7.63 (d, J = 7.9 Hz, 1H), 7.53 (t, J = 7.9 Hz, 1H), 7.29 (s, 1H), 3.82 (s, 3H), 2.21 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 164.7, 156.2, 140.0, 131.6 (q, JF–C = 1.2 Hz), 131.2, 130.6 (q, JF–C = 32.3 Hz), 128.6, 125.6 (q, JF–C = 3.8 Hz), 125.4 (q, JF–C = 4.0 Hz), 124.1 (q, JF–C = 271.0 Hz), 123.0, 115.1, 51.5, 10.2; IR (neat): νmax/cm−1 1720, 1604, 1547, 1479, 1439, 1381, 1331, 1283, 1213, 1168, 1128, 1073, 1001; HRMS (ESI): m/z calcd for C14H11F3NaO3: 307.0553 [M + Na]+; found 307.0558.
Methyl 2-(2′-bromophenyl)-4-methylfuran-3-carboxylate (3f). The crude product was purified by column chromatography on silica gel (0.5% ethyl acetate in petroleum ether) to give 3f as a colorless oil; yield 80%; 1H NMR (400 MHz, CDCl3): δ 7.65 (m, 1H), 7.45 (m, 1H), 7.37 (m, 1H), 7.28 (m, 1H), 6.44 (q, J = 1.0 Hz, 1H), 3.70 (s, 3H), 2.36 (d, J = 1.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 163.8, 155.0, 152.3, 133.0, 132.3, 132.1, 130.8, 126.9, 124.1, 116.8, 107.2, 51.6, 13.6; IR (neat): νmax/cm−1 1722, 1570, 1467, 1438, 1383, 1276, 1209, 1102, 1058, 1012; HRMS (ESI): m/z calcd for C13H1279BrO3: 294.9964 [M + H]+; found 294.9965.
Methyl 2-(2′,4′-dimethoxyphenyl)-4-methylfuran-3-carboxylate (3g). The crude product was purified by column chromatography on silica gel (2% ethyl acetate in petroleum ether) to give 3g as an orange oil; yield 82%; 1H NMR (400 MHz, CDCl3): δ 7.36 (d, J = 8.4 Hz, 1H), 7.22 (q, J = 1.0 Hz, 1H), 6.54 (dd, J = 8.4, 2.3 Hz, 1H), 6.49 (d, J = 2.3 Hz, 1H), 3.82 (s, 3H), 3.75 (s, 3H), 3.69 (s, 3H), 2.18 (d, J = 1.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 165.2, 161.9, 158.2, 154.9, 138.9, 131.4, 121.6, 115.4, 113.0, 104.4, 98.6, 55.5, 55.4, 51.1, 9.7; IR (neat): νmax/cm−1 1717, 1618, 1504, 1438, 1292, 1211, 1161, 1090, 1032; HRMS (ESI): m/z calcd for C15H17O5: 277.1071 [M + H]+; found 277.1071.
Methyl 2-(6′-methoxynaphthalen-2′-yl)-4-methylfuran-3-carboxylate (3h). The crude product was purified by column chromatography on silica gel (1% ethyl acetate in petroleum ether) to give 3h as a colorless solid; yield 80%; mp 114 °C; 1H NMR (400 MHz, CDCl3): δ 8.24 (s, 1H), 7.84–7.73 (m, 3H), 7.28 (q, J = 1.0 Hz, 1H), 7.17–7.13 (m, 2H), 3.93 (s, 3H), 3.82 (s, 3H), 2.22 (d, J = 1.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 165.2, 158.6, 158.5, 139.2, 134.9, 130.0, 128.4, 128.0, 126.4, 126.3, 125.7, 122.7, 119.3, 113.8, 105.7, 55.5, 51.4, 10.4; IR (neat): νmax/cm−1 1713, 1627, 1592, 1537, 1504, 1479, 1458, 1392, 1378, 1302, 1287, 1273, 1258, 1202, 1164, 1119, 1093, 1069, 1029; HRMS (ESI): m/z calcd for C18H16NaO4: 319.0946 [M + Na]+; found 319.0943.
Methyl 4-methyl-2-(N-tosyl-1H-pyrrol-3′-yl)furan-3-carboxylate (3i). The crude product was purified by column chromatography on silica gel (7% ethyl acetate in petroleum ether) to give 3i as an orange oil; yield 78%; 1H NMR (400 MHz, CDCl3): δ 8.06 (m, 1H), 7.80 (d, J = 8.4 Hz, 2H), 7.30 (d, J = 8.4 Hz, 2H), 7.16 (m, 1H), 7.11 (q, J = 1.0 Hz, 1H), 6.84 (m, 1H), 3.85 (s, 3H), 2.40 (s, 3H), 2.15 (d, J = 1.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 164.9, 153.7, 145.4, 138.3, 135.9, 130.3, 127.2, 122.3, 121.1, 120.7, 119.3, 113.1, 112.9, 51.4, 21.8, 10.6; IR (neat): νmax/cm−1 1713, 1606, 1538, 1494, 1474, 1454, 1438, 1373, 1303, 1231, 1214, 1174, 1117, 1018; HRMS (ESI): m/z calcd for C18H17NNaO5S: 382.0720 [M + Na]+; found 382.0723.
Diethyl 4,4′′-dimethyl-[2,2′:5′,2′′-terfuran]-3,3′′-dicarboxylate (3j). The crude product was purified by column chromatography on silica gel (5% ethyl acetate in petroleum ether) to give 3j as a yellow solid; yield 60%; mp 175 °C; 1H NMR (400 MHz, CDCl3): δ 7.54 (s, 2H), 7.27 (q, J = 1.2 Hz, 2H), 4.37 (q, J = 3.6 Hz, 4H), 2.21 (d, J = 1.2 Hz, 6H), 1.39 (t, J = 3.6 Hz, 6H); 13C NMR (100 MHz, CDCl3): δ 163.8, 149.1, 145.1, 139.7, 122.7, 114.8, 114.2, 60.6, 14.4, 10.5; IR (KBr): νmax/cm−1 1701, 1600, 1523, 1307, 1231, 1122, 1101, 1024; HRMS (ESI): m/z calcd for C20H20NaO7: 395.1101 [M + Na]+; found 395.1098.
Ethyl 2,4-dimethylfuran-3-carboxylate (3k). The crude product was purified by column chromatography on silica gel (petroleum ether) to give 3k as a colorless oil; yield 85%; 1H NMR (400 MHz, CDCl3): δ 7.01 (q, J = 1.1 Hz, 1H), 4.27 (q, J = 7.2 Hz, 2H), 2.52 (s, 3H), 2.12 (d, J = 1.1 Hz, 3H), 1.34 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 165.0, 160.2, 137.7, 121.3, 113.6, 59.9, 14.5, 14.5, 10.2; IR (neat): νmax/cm−1 1716, 1611, 1563, 1418, 1385, 1298, 1272, 1099; HRMS (ESI): m/z calcd for C9H13O3: 169.0859 [M + H]+; found 169.0858.
Ethyl 2-isopropyl-4-methylfuran-3-carboxylate (3l). The crude product was purified by column chromatography on silica gel (petroleum ether) to give 3l as a colorless oil; yield 76%; 1H NMR (400 MHz, CDCl3): δ 7.03 (q, J = 1.2 Hz, 1H), 4.28 (q, J = 7.1 Hz, 2H), 3.71 (heptet, J = 7.0 Hz, 1H), 2.12 (d, J = 1.2 Hz, 3H), 1.34 (t, J = 7.1 Hz, 3H), 1.23 (d, J = 7.0 Hz, 6H); 13C NMR (100 MHz, CDCl3): δ 168.0, 164.9, 137.7, 121.0, 111.8, 59.9, 27.7, 20.8, 14.4, 10.2; IR (neat): νmax/cm−1 1718, 1560, 1282, 1210, 1065; HRMS (ESI): m/z calcd for C11H17O3: 197.1172 [M + H]+; found 197.1173.
Methyl 4-ethyl-2-(4′-methylphenyl)furan-3-carboxylate (3m). The crude product was purified by column chromatography on silica gel (0.3% ethyl acetate in petroleum ether) to give 3m as a yellow oil; yield 60%; 1H NMR (400 MHz, CDCl3): δ 7.65 (d, J = 8.2 Hz, 2H), 7.24–7.22 (m, 3H), 3.80 (s, 3H), 2.67 (qd, J = 7.4, 1.0 Hz, 2H), 2.39 (s, 3H), 1.23 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 165.1, 158.5, 139.2, 138.3, 129.3, 128.9, 128.4, 127.8, 112.9, 51.4, 21.5, 18.5, 13.8; IR (neat): νmax/cm−1 1716, 1500, 1437, 1293, 1208, 1077; HRMS (ESI): m/z calcd for C15H17O3: 245.1172 [M + H]+; found 245.1170.
Methyl 2-(4′-methylphenyl)-4,5,6,7-tetrahydrobenzofuran-3-carboxylate (2n). The crude product was purified by column chromatography on silica gel (petroleum ether) to give 2n as a colorless oil; yield 11%; 1H NMR (400 MHz, CDCl3): δ 7.72 (d, J = 8.2 Hz, 2H), 7.21 (d, J = 8.2 Hz, 2H), 3.79 (s, 3H), 2.66–2.61 (m, 4H), 2.38 (s, 3H), 1.88–1.73 (m, 4H); 13C NMR (100 MHz, CDCl3): δ 165.2, 156.3, 150.7, 138.9, 128.8, 128.3, 127.9, 119.1, 112.8, 51.3, 23.2, 23.0, 22.8, 22.7, 21.6; IR (neat): νmax/cm−1 1720, 1557, 1501, 1438, 1283, 1217, 1095, 1037; HRMS (ESI): m/z calcd for C17H19O3: 271.1329 [M + H]+; found 271.1328.
Ethyl 4-benzyl-2-isopropylfuran-3-carboxylate (3o). The crude product was purified by column chromatography on silica gel (0.5% ethyl acetate in petroleum ether) to give 3o as a colorless oil; yield 71%; 1H NMR (400 MHz, CDCl3): δ 7.32–7.21 (m, 5H), 6.18 (s, 1H), 4.23 (q, J = 7.1 Hz, 2H), 3.91 (s, 1H), 3.73 (heptet, J = 7.0 Hz, 1H), 1.30 (t, J = 7.1 Hz, 3H), 1.25 (d, J = 7.0 Hz, 6H); 13C NMR (100 MHz, CDCl3): δ 166.4, 164.2, 152.3, 137.6, 128.8, 128.6, 126.7, 112.2, 107.0, 60.0, 34.3, 27.3, 20.9, 14.4; IR (neat): νmax/cm−1 1715, 1576, 1497, 1468, 1455, 1381, 1208, 1059; HRMS (ESI): m/z calcd for C17H21O3: 273.1485 [M + H]+; found 273.1483.

Acknowledgements

We are grateful to Zhengzhou University (#1421316040) and the NSFC (#81330075; #21172202) for financial support.

References and notes

  1. H. Shinonaga, Y. Kawamura, A. Ikeda, M. Aoki, N. Sakai, N. Fujimoto and A. Kawashima, Tetrahedron Lett., 2009, 50, 108–110 CrossRef CAS PubMed.
  2. L. Vasamsetty, F. A. Khan and G. Mehta, Tetrahedron Lett., 2014, 55, 7068–7071 CrossRef CAS PubMed.
  3. S. Wang, L. Bao, F. Zhao, Q. Wang, S. Li, J. Ren, L. Li, H. Wen, L. Guo and H. Liu, J. Agric. Food Chem., 2013, 61, 5122–5129 CrossRef CAS PubMed.
  4. B. H. Lipshutz, Chem. Rev., 1986, 86, 795–819 CrossRef CAS.
  5. (a) G. Minetto, L. F. Raveglia and M. Taddei, Org. Lett., 2004, 6, 389–392 CrossRef CAS PubMed; (b) M. Yuguchi, M. Tokuda and K. Orito, J. Org. Chem., 2004, 69, 908–914 CrossRef CAS PubMed.
  6. (a) Y.-F. Chen, H.-F. Wang, Y. Wang, Y.-C. Luo, H.-L. Zhu and P.-F. Xu, Adv. Synth. Catal., 2010, 352, 1163–1168 CrossRef CAS PubMed; (b) E. Nakamura, H. Tsuji, K.-I. Yamagata and Y. Ueda, Synlett, 2011, 1015–1017 Search PubMed; (c) H. Imagawa, T. Kurisaki and M. Nishizawa, Org. Lett., 2004, 6, 3679–3681 CrossRef CAS PubMed; (d) M. Y. Chang, Y. C. Cheng and Y. J. Lu, Org. Lett., 2015, 17, 1264–1267 CrossRef CAS PubMed; (e) A. Rodríguez and W. J. Moran, Tetrahedron Lett., 2011, 52, 2605–2607 CrossRef PubMed; (f) A. Saito, T. Anzai, A. Matsumoto and Y. Hanzawa, Tetrahedron Lett., 2011, 52, 4658–4661 CrossRef CAS PubMed; (g) M. Tiecco, L. Testaferri, M. Tingoli and F. Marini, Synlett, 1994, 373–374 CrossRef CAS; (h) R. A. Kretchmer and R. A. Laitar, J. Org. Chem., 1978, 43, 4596–4598 CrossRef CAS; (i) R. Antonioletti, F. Bonadies and A. Scettri, Tetrahedron Lett., 1988, 29, 4987–4990 CrossRef CAS; (j) D. Schmidt, C. C. Malakar and U. Beifuss, Org. Lett., 2014, 16, 4862–4865 CrossRef CAS PubMed; (k) L. Chen, Y. Fang, Q. Zhao, M. Shi and C. Li, Tetrahedron Lett., 2010, 51, 3678–3681 CrossRef CAS PubMed; (l) Y. Fang and C. Li, Chem. Commun., 2005, 3574–3576 RSC.
  7. (a) A. S. K. Hashmi, L. Schwarz, J.-H. Choi and T. M. Frost, Angew. Chem., Int. Ed., 2000, 112, 2382–2385 CrossRef; (b) J. A. Marshall and X.-J. Wang, J. Org. Chem., 1991, 56, 960–969 CrossRef CAS.
  8. (a) B. Gabriele, G. Salerno, F. de Pascali, M. Costa and G. P. Chiusoli, J. Org. Chem., 1999, 64, 7693–7699 CrossRef CAS; (b) B. Gabriele, G. Salerno and E. Lauria, J. Org. Chem., 1999, 64, 7687–7692 CrossRef CAS; (c) A. S. K. Hashmi, T. Häffner, M. Rudolph and F. Rominger, Eur. J. Org. Chem., 2011, 667–671 CrossRef CAS PubMed; (d) Y. Liu, F. Song, Z. Song, M. Liu and B. Yan, Org. Lett., 2005, 7, 5409–5412 CrossRef CAS PubMed; (e) F. E. McDonald and C. C. Schultz, J. Am. Chem. Soc., 1994, 116, 9363–9364 CrossRef CAS.
  9. (a) A. S. K. Hashmi and P. Sinha, Adv. Synth. Catal., 2004, 346, 432–438 CrossRef PubMed; (b) P. Pale and J. Chuche, Tetrahedron Lett., 1987, 28, 6447–6448 CrossRef CAS.
  10. (a) H. Jiang, W. Yao, H. Cao, H. Huang and D. Cao, J. Org. Chem., 2010, 75, 5347–5350 CrossRef CAS PubMed; (b) M. H. Suhre, M. Reif and S. F. Kirsch, Org. Lett., 2005, 7, 3925–3927 CrossRef CAS PubMed.
  11. For a recent review, see: M. Álvarez-Corral, M. Muñoz-Dorado and I. Rodríguez-García, Chem. Rev., 2008, 108, 3174–3198 CrossRef PubMed.
  12. C. He, J. Hao, H. Xu, Y. Mo, H. Liu, J. Han and A. Lei, Chem. Commun., 2012, 48, 11073–11075 RSC.
  13. C. He, S. Guo, J. Ke, J. Hao, H. Xu, H. Chen and A. Lei, J. Am. Chem. Soc., 2012, 134, 5766–5769 CrossRef CAS PubMed.
  14. J. Ke, C. He, H. Liu, M. Li and A. Lei, Chem. Commun., 2013, 49, 7549–7551 RSC.
  15. (a) F. Liu, X. Ding, L. Zhang, Y. Zhou, L. Zhao, H. Jiang and H. Liu, J. Org. Chem., 2010, 75, 5810–5820 CrossRef CAS PubMed; (b) H. Wang, S. Jiao, K. Chen, X. Zhang, L. Zhao, D. Liu, Y. Zhou and H. Liu, Beilstein J. Org. Chem., 2015, 11, 416–424 CrossRef CAS PubMed; (c) H. M. Wisniewska and E. R. Jarvo, Chem. Sci., 2011, 2, 807–810 RSC.
  16. (a) J. J. Mousseau, J. A. Bull, C. L. Ladd, A. Fortier, D. Sustac Roman and A. B. Charette, J. Org. Chem., 2011, 76, 8243–8261 CrossRef CAS PubMed; (b) J. J. Mousseau, A. Fortier and A. B. Charette, Org. Lett., 2010, 12, 516–519 CrossRef CAS PubMed.
  17. N. Krause, Ö. Aksin-Artok, M. Asikainen, V. Breker, C. Deutsch, J. Erdsack, H.-T. Fan, B. Gockel, S. Minkler, M. Poonoth, Y. Sawama, Y. Sawama, T. Sun, F. Volz and C. Winter, J. Organomet. Chem., 2012, 704, 1–8 CrossRef CAS PubMed.
  18. W. F. Berkowitz and P. J. Wilson, J. Org. Chem., 1991, 56, 3097–3102 CrossRef CAS.
  19. ESI..
  20. A. S. Demir, I. M. Akhmedov and Ö. Sesenoglu, Tetrahedron, 2002, 58, 9793–9799 CrossRef CAS.
  21. Activation of allenic intermediate I by silver, followed by cyclization into the furan derivatives is not excluded.
  22. (a) S. Ma, L. Lu and J. Zhang, J. Am. Chem. Soc., 2004, 126, 9645–9660 CrossRef CAS PubMed; (b) S. Ma and J. Zhang, Angew. Chem., Int. Ed., 2003, 42, 183–187 CrossRef CAS PubMed.
  23. L. Lu, G. Chen and S. Ma, Org. Lett., 2006, 8, 835–838 CrossRef CAS PubMed.
  24. B. Gabriele, R. Mancuso, V. Maltese, L. Veltri and G. Salerno, J. Org. Chem., 2012, 77, 8657–8668 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available: CCDC 1413437. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5ra14273c

This journal is © The Royal Society of Chemistry 2015
Click here to see how this site uses Cookies. View our privacy policy here.